Skip to content
Pharma Observatory a Scientist.com platform

Organization (Nonprofit)

Oregon Research Institute

ClinicalTrials.gov lists Oregon Research Institute as lead sponsor of 70 trials.

US Nonprofit
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

10 0 1991 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Oregon Research Institute: 70 lead-sponsored trials and 1 legal-entity registration.

Get the Oregon Research Institute report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (29)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Substance-Related Disorders 18
Obesity 14
Feeding and Eating Disorders 11
Diabetes Mellitus 5
Diabetes Mellitus, Type 2 5

Trials by start year as sponsor or collaborator (28)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 2
2025 1
2024 3
2023 6
2022 2
2021 3
2020 1
2019 1
2018 3
2017 3

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
62% hit target (n=13) 36% on time (n=14)

Journals published in (122)

Shown in this order: most published in first.

Journals published in
Journal Publications
Journal of consulting and clinical psychology 22
The International journal of eating disorders 10
The American journal of clinical nutrition 9
Behaviour research and therapy 8
Journal of abnormal psychology 7

Financing and grant events (27)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2025-09-24 NIH grant 744,612 Reporter
2025-03-12 NIH grant 957,329 Reporter
2024-11-19 NIH grant 101,108 Reporter
2024-07-30 NIH grant 293,274 Reporter
2024-04-23 NIH grant 79,300 Reporter

Latest dated events (118)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-06-08 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-24 NIH grant Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2025-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-03-12 NIH grant Funding rounds and grants (NIH RePORTER + SEC EDGAR)

CLIA clinical laboratory certificates (3)

Shown in this order: active first, then certificate type.

CLIA clinical laboratory certificates
Lab Certificate Status
OREGON RESEARCH INSTITUTE Certificate of waiver Active
OREGON RESEARCH INSTITUTE Certificate of compliance Terminated
OREGON RESEARCH INSTITUTE Certificate of compliance Terminated

Biomarkers this organization publishes on (31)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
INS 13
DRD2 6
ANKK1 5
DRD4 3
LEP 3

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, us granted patents, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, and biomarker capability evidence.